D.E. Shaw & Co
DMAQR

D.E. Shaw & Co’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

D.E. Shaw & Co’s Portfolio DMAQR Stock Details DMAQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-296,800
Closed -$89K – 4905
2023
Q4 		$89K Hold
296,800
– – ﹤0.01% 3986
2023
Q3 		$89K Hold
296,800
– – ﹤0.01% 3869
2023
Q2 		$47.5K Hold
296,800
– – ﹤0.01% 3884
2023
Q1 		$41.6K Hold
296,800
– – ﹤0.01% 4058
2022
Q4 		$14.8K Hold
296,800
– – ﹤0.01% 4563
2022
Q3 		$11K Hold
296,800
– – ﹤0.01% 4924
2022
Q2 		$33K Hold
296,800
– – ﹤0.01% 4913
2022
Q1 		$53K Sell
296,800
-183,200
-38% -$46.3K ﹤0.01% 5134
2021
Q4 		$154K Buy
+480,000
New +$152K ﹤0.01% 4958

D.E. Shaw & Co's DMAQR Position: Q1 2024 in Review

D.E. Shaw & Co sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 296,800 shares — an estimated $89K sold.

D.E. Shaw & Co first reported a position in DMAQR in Q4 2021 and held it in 9 quarters. The position peaked at $154K in Q4 2021. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

  • D.E. Shaw & Co reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 296,800 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $89K.
  • D.E. Shaw & Co first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 9 quarters.
  • D.E. Shaw & Co's Deep Medicine Acquisition Corp. Rights position peaked at $154K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.